Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02782130 · ClinicalTrials.gov registry record · NA

Epic Allies HIV ART Adherence Intervention

A NA study, sponsored by University of North Carolina, Chapel Hill.

Completed
Registry status
NA
Development phase
146
Enrollment target

NCT02782130: Completed NA study, sponsored by University of North Carolina, Chapel Hill.

NCT02782130 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 146 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02782130, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.

COMPLETED
Registry status
NA
Development phase
146 participants
Enrollment target

Study Summary

This is a two-arm, randomized-controlled trial (RCT) that will test the acceptability, impact, and long-term sustainability of the Epic Allies intervention application (app), a theory-based mobile app that utilizes game mechanics and social networking features to improve engagement in care, antiretroviral therapy (ART) uptake, ART adherence, and viral suppression among HIV-positive young men who have sex with men (YMSM) and trans women who have sex with men. Subjects will be randomized to either the intervention branch of the Epic Allies app or the control branch of the app.

Primary Outcome

VL suppression at 13 weeks is defined as VL below the lower limit of detection (LLD) in the six-week window before the Week 13 visit.

Interventions

  • BEHAVIORAL Epic Allies App Intervention
  • BEHAVIORAL Epic Allies - Control Branch

Trial Details

FieldValue
Enrollment Target 146 participants
Start Date 2015-06
Est. Completion 2017-12-14
Phase NA

What the finished NCT02782130 record still lists

NCT02782130 is an interventional study that assigns participants to a tested intervention. The registered 146 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 2 interventions - of which Epic Allies App Intervention is the first listed.

NCT02782130 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02782130 about?

NCT02782130 is a clinical study titled "Epic Allies HIV ART Adherence Intervention". This is a two-arm, randomized-controlled trial (RCT) that will test the acceptability, impact, and long-term sustainability of the Epic Allies intervention application (app), a theory-based mobile app that utilizes game mechanics and social networking features to improve engagement in care, antiretr...

What is the current status of trial NCT02782130?

This trial is currently completed. It is a NA study. The enrollment target is 146 participants. The study started on 2015-06. Estimated completion is 2017-12-14.

What interventions are being tested in trial NCT02782130?

The interventions under investigation include: Epic Allies App Intervention (BEHAVIORAL), Epic Allies - Control Branch (BEHAVIORAL).

Who is sponsoring clinical trial NCT02782130?

This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02782130's enrollment target sits among peer trials

146 704th of 2000 higher than 1,296 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03490929 · 146 participants · Phase 4

    CEUS for Blunt Abdominal Trauma in Children

  • NCT04755062 · 146 participants · NA

    A Culturally-relevant Micronutrient-dense Plant-rich (mNDPR) Dietary Intervention for Native Americans

  • NCT04867954 · 146 participants

    Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis

  • NCT05051618 · 146 participants · NA

    Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02782130, the US trial registry maintained by the National Library of Medicine. NCT02782130 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.